IU to spend $250M on new life-science institutes in Indy, faculty, labs, research
IU’s newest plans are intended to bolster enrollment and establish Indiana University Indianapolis as one of the country’s premier urban research universities.
John Russell
Articles
Eskenazi Hospital to expand therapy dog program with $1M gift
At Eskenazi and other hospitals around central Indiana, therapy dogs are seen as part of the health care team—furry healing agents who bring smiles to patients, and perhaps even more.
Higher costs of wages, supplies shrink Community Health’s operating income
Community Health Network said Thursday that operating income fell 38% in the first nine months of the year as higher expenses ate into the bottom line.
IU Health Foundation launches $200M fundraising campaign
Indiana University Health Foundation, the fundraising arm of IU Health’s adult hospitals, is launching the campaign with the ambitious goal of making Indiana one of the healthiest states in the country.
Life science boosters hail Indiana’s designation as federal technology hub
The federal designation marks Indiana as a hub for biologics manufacturing. Biologics are medicines derived from biological sources and include vaccines, monoclonal antibodies, and immune modulators.
Woman to plead guilty of leading conspiracy that defrauded Lilly of more than $600K
According to the petition Courtney Anguiano knowingly conspired with seven other people to submit 189 false and fraudulent post-transaction reimbursement requests under three different Eli Lilly and Co. savings card programs.
Point Biopharma insiders to reap millions from Lilly deal
Top executives and directors of Indianapolis-based Point Biopharma Global Inc. could rake in an eye-popping $212 million from their deal to sell the company to drugmaker Eli Lilly and Co.
State’s newest public company faces hurdles
Syra Health Corp., a Carmel-based health care services company, raised $5.3 million after expenses in its initial public offering. But it faces a slew of challenges, from winning new customers to launching products and services quickly to stem losses.
Nearly two-thirds of serious mental health needs unmet in Marion County, report says
The latest report, called “Community Mental Health Needs Assessment Report for Marion County,” estimates that nearly 26,000 residents who needed treatment for a mental illness in 2022 did not receive it.
Federal government repaying Indiana hospitals $222M for improper reimbursement cuts
After a bruising, five-year fight that went all the way to the U.S. Supreme Court, hospitals across Indiana and the nation are in line for a huge payday.
New UAW president, a Kokomo native, pushing hard, raising expectations
In just a few months, Shawn Fain has gone from obscurity to one of the most visible leaders in America, demanding that his workers get more concessions from the Big Three automakers after two decades of givebacks.
Lilly buys radiopharmaceutical startup Point Biopharma for $1.4B
Eli Lilly and Co. is paying Indianapolis-based startup Point Biopharma $12.50 a share, an 85% premium over the company’s closing price on Monday of $6.68 a share.
FDA rejects Lilly drug for eczema due to inspection issues at outside manufacturer
Eli Lilly and Co. just hit another bump in the road in its quest to push deeper into treatments for skin diseases, the third setback this year for the Indianapolis-based drugmaker from the U.S Food and Drug Administration.
Indiana health providers raise alarm on drug shortages
About 99% of pharmacists who responded to a recent survey by the American Society of Health System Pharmacists said they are experiencing drug shortages. About a third said the shortages are leading to rationing, delaying or canceling treatments or procedures.
Journalism group cancels 2024 convention in Indy, citing budget crisis
Membership at the Society of Professional Journalists has fallen from more than 10,000 a decade ago to about 4,100 this year.
Judge overturns $176.5M jury verdict against Lilly in patent infringement suit
The decision represents a rare case of a judge overturning a jury verdict and is a major win for Lilly, which argued strenuously that its Emgality drug is substantially different than Anjovy, a drug sold by competitor Teva Pharmaceuticals.
Made in Indiana: Hospital beds by Hill-Rom Holdings Inc. (a subsidiary of Baxter International)
The operation’s primary factory and administration remain in Batesville, where more than 900 people work.
Corteva sues startup rival Inari for patent infringement
The lawsuit seeks to prevent Inari “from continuing its brazen efforts to steal Corteva’s groundbreaking, patent-protected work,” according to the complaint.
Halverson leaving IU Fairbanks School of Public Health for Oregon job
Paul Halverson, the founding dean of the Indiana University Fairbanks School of Public Health, is a longtime advocate for a stronger role for public health across the state.
Lilly to install $10M worth of solar panels at two Indianapolis campuses
The solar structures are designed to help generate power for the company and reduce its carbon footprint.